Research Article
Clinical Implications and Prognostic Values of Prostate Cancer Susceptibility Candidate Methylation in Primary Nonmuscle Invasive Bladder Cancer
Table 1
Baseline characteristics of subjects.
| | Variables | NC () | NMIBC () |
| | Age, yrs (mean) | 59.0 ± 22.2 | 64 ± 13.4 | | Gender, number of patients (%) | | | | Male | 6 (75.0) | 107 (83.6) | | Female | 2 (25.0) | 21 (16.4) | | Number of tumors (%) | | | | Single | — | 76 (59.4) | | Multiple | — | 52 (40.6) | | Tumor size (%) | | | | <3 cm | — | 76 (59.4) | | ≥3 cm | — | 52 (40.6) | | Grade, number of patients (%) | | | | G1 | — | 38 (29.7) | | G2 | — | 72 (56.2) | | G3 | — | 18 (14.1) | | T Stage | | | | Ta | — | 47 (36.7) | | T1 | — | 81 (63.3) | | Intravesical treatment, number of patients (%) | | | | No | — | 58 (45.3) | | Yes | — | 70 (54.7) | | Recurrence-free survival, months (median) | | 44.5 (6.2–160.7) | | Recurrence, number of patients (%) | | | | No | — | 90 (70.3) | | Yes | — | 38 (29.7) | | Progression-free survival, months (median) | | 51.0 (6.6–160.7) | | Progression, number of patients (%) | | | | No | — | 113 (88.3) | | Yes | — | 15 (11.7) |
|
|
NC: normal control; NMIBC: nonmuscle invasive bladder cancer.
|
